News Focus
News Focus
Post# of 257253
Next 10
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 103015

Thursday, 10/28/2010 1:51:47 AM

Thursday, October 28, 2010 1:51:47 AM

Post# of 257253
Ipsen’s 3Q10 worldwide sales of Dysport rose 22% YoY and 9% QoQ to $71M (€51.8M), but US sales in non-cosmetic indications were de minimis:

http://finance.yahoo.com/news/Ipsens-First-Nine-Months-of-bw-560199592.html?x=0&.v=1

Worldwide in all indications combined, AGN’s Botox outsells Dysport by about 8:1.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now